Showing results (41-50 of 117) with videos related to
Sort By:
Pageof 12
Alzheimer'S Research & Therapy|February 27, 2015
The monoaminergic footprint of depression and psychosis in dementia with Lewy bodies compared to Alzheimer's diseaseYannick Vermeiren, Debby Van Dam, Tony Aerts, et al.Clinical Parkinsonism & Related Disorders|June 9, 2025
Correlation analyses between MIBG myocardial scintigraphy and monoamine levels in dementia with Lewy bodies show potential link with the serotonergic systemAnnelies Heylen, Yannick Vermeiren, Sebastiaan Engelborghs, et al.Immunity & Ageing : I & A|August 21, 2025
Systemic inflammation as a central player in the initiation and development of Alzheimer's diseaseIrem Bayraktaroglu, Natalia Ortí-Casañ, Debby Van Dam, et al.Fluids and Barriers of the CNS|June 30, 2015
A new glaucoma hypothesis: a role of glymphatic system dysfunctionPeter Wostyn, Debby Van Dam, Kurt Audenaert, et al.Journal of the Neurological Sciences|March 29, 2005
Biochemical and behavioural phenotyping of a mouse model for GAMT deficiencyAn Torremans, Bart Marescau, Ilse Possemiers, et al.International Journal of Molecular Sciences|March 10, 2022
Short-Term Pharmacological Induction of Arterial Stiffness and Hypertension with Angiotensin II Does Not Affect Learning and Memory and Cerebral Amyloid Load in Two Murine Models of Alzheimer's DiseaseJhana O Hendrickx, Elke Calus, Peter Paul De Deyn, et al.Behavioral Neuroscience|June 3, 2008
Altered ingestive behavior, weight changes, and intact olfactory sense in an APP overexpression modelEllen Vloeberghs, Debby Van Dam, Frieda Franck, et al.Neurochemistry International|March 2, 2005
Analysis of cholinergic markers, biogenic amines, and amino acids in the CNS of two APP overexpression mouse modelsDebby Van Dam, Bart Marescau, Sebastiaan Engelborghs, et al.Biomed Research International|September 27, 2017
The Glymphatic Hypothesis of Glaucoma: A Unifying Concept Incorporating Vascular, Biomechanical, and Biochemical Aspects of the DiseasePeter Wostyn, Veva De Groot, Debby Van Dam, et al.Life (Basel, Switzerland)|October 28, 2023
Behavioral and Neuropathological Phenotyping of the Tau58/2 and Tau58/4 Transgenic Mouse Models for FTDP-17Debby Van Dam, Femke Valkenburg, Kristof Van Kolen, et al.Pageof 12